Please assess the completion status of the following clinical trial:

Trial Title: Boron Neutron Capture Therapy (BNCT) as Treatment of Glioblastoma

Study Design Characteristics:
- Allocation: NON_RANDOMIZED
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE1/PHASE2
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Histologically confirmed glioblastoma multiforme~* Supratentorial location~* At least 30% of the tumor volume has been removed at craniotomy as judged from a pre/perioperative MRI~* Ability to understand the concept of investigational therapy~* Tolerates dexamethasone treatment~* Adequate anti-epileptic medication~* BNCT can be delivered within 6 weeks from the date of brain surgery~* A written informed consent~Exclusion Criteria:~* Age less than 18 or greater than 75~* The tumor infiltrates into the optic chiasm or into the deep parts of the brain prohibiting delivery of an adequate radiation dose with BNCT~* Prior radiation therapy to the brain~* Prior chemotherapy, immunotherapy, or gene therapy~* Karnofsky performance score \<70~* Severe cardiac, liver, or kidney failure~* Severe infection~* A cardiac pace-maker, or a metal implant in the head and neck region that will prohibit MRI examination~* Pregnancy or lactation~* Phenylketonuria

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 75 Years
- Healthy Volunteers: f

Study Arms:
- A (Type: EXPERIMENTAL): Active treatment arm.

Based on this trial design, predict the completion outcome and termination type (if applicable).